InsiderTrades.com logo

FNCH Insider Trading

Insider Ownership Percentage: 44.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Finch Therapeutics Group Insider Trading History Chart

This chart shows the insider buying and selling history at Finch Therapeutics Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Finch Therapeutics Group Share Price & Price History

Current Price: $13.62
Price Change: ▲ Price Increase of +0.42 (3.18%)
As of 12/4/2025 04:59 PM ET

This chart shows the closing price history over time for FNCH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Finch Therapeutics Group Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/28/2024Jeffery A. SmisekDirectorSell6,642$2.57$17,069.94View SEC Filing Icon  
11/22/2023Jeffery A. SmisekDirectorSell1,470$3.64$5,350.806,642View SEC Filing Icon  
2/21/2023Marc BlausteinCOOSell153$11.40$1,744.20933View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Finch Therapeutics Group (NASDAQ:FNCH)

21.77% of Finch Therapeutics Group stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at FNCH by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Finch Therapeutics Group Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2024Lake Street Advisors Group LLC21,206$56K0.0%N/A1.317%Search for SEC Filing on Google Icon
11/15/2023MSD Partners L.P.5,113$26K0.0%N/A0.318%Search for SEC Filing on Google Icon
8/11/2023Baupost Group LLC MA67,296$0.57M0.0%-96.7%4.206%Search for SEC Filing on Google Icon
8/10/2023Lake Street Advisors Group LLC21,206$0.23M0.0%-97.1%1.323%Search for SEC Filing on Google Icon
5/12/2023Baupost Group LLC MA2,019,008$0.79M0.0%+98.1%4.194%Search for SEC Filing on Google Icon
11/14/2022Boothbay Fund Management LLC23,887$40K0.0%-42.1%0.050%Search for SEC Filing on Google Icon
11/14/2022Aperture Investors LLC192,794$0.32M0.1%-7.2%0.404%Search for SEC Filing on Google Icon
11/9/2022SVB Wealth LLC253,054$0.42M0.0%N/A0.531%Search for SEC Filing on Google Icon
11/7/2022Virtu Financial LLC15,190$25K0.0%N/A0.032%Search for SEC Filing on Google Icon
8/11/2022Wealthsource Partners LLC11,500$33K0.0%N/A0.024%Search for SEC Filing on Google Icon
5/9/2022Qube Research & Technologies Ltd37,631$0.19M0.0%+53.6%0.079%Search for SEC Filing on Google Icon
2/16/2022Lake Street Advisors Group LLC739,136$7.37M0.5%+16.2%1.557%Search for SEC Filing on Google Icon
2/15/2022Light Street Capital Management LLC811,731$8.09M0.5%+1.8%1.710%Search for SEC Filing on Google Icon
2/14/2022SCS Capital Management LLC38,294$0.38M0.0%N/A0.081%Search for SEC Filing on Google Icon
2/14/2022Avenir Management Company LLC1,663,366$16.58M8.9%N/A3.503%Search for SEC Filing on Google Icon
2/11/2022Baupost Group LLC MA1,132,253$11.29M0.1%-6.3%2.385%Search for SEC Filing on Google Icon
2/10/2022Qube Research & Technologies Ltd24,503$0.24M0.0%N/A0.052%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp67,445$0.67M0.0%-2.7%0.142%Search for SEC Filing on Google Icon
2/1/2022Qube Research & Technologies Ltd24,503$0.24M0.0%N/A0.052%Search for SEC Filing on Google Icon
11/16/2021Laurion Capital Management LP58,000$0.75M0.0%-3.3%0.122%Search for SEC Filing on Google Icon
11/16/2021MSD Partners L.P.388,691$5.05M0.3%+65.2%0.819%Search for SEC Filing on Google Icon
11/15/2021Ancora Advisors LLC6,946$90K0.0%+73.7%0.015%Search for SEC Filing on Google Icon
11/15/2021Lake Street Advisors Group LLC636,195$8.27M0.9%N/A1.341%Search for SEC Filing on Google Icon
11/15/2021HighTower Advisors LLC18,099$0.24M0.0%+21.6%0.038%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC153,549$2M0.0%+9.3%0.324%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.387,339$5.04M0.0%+2.9%0.816%Search for SEC Filing on Google Icon
11/8/2021TRB Advisors LP570,000$7.41M2.7%+3.6%1.201%Search for SEC Filing on Google Icon
10/27/2021Ballentine Partners LLC143,603$1.87M0.1%N/A0.303%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC65,141$0.92M0.0%-68.4%0.137%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Finch Therapeutics Group logo
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company develops FIN-211, a microbiome candidate designed to address the gastrointestinal and behavioral symptoms of autism spectrum disorder; and FIN-524 for the prevention, diagnosis, theragnosis or treatment of diseases in humans, including ulcerative colitis; FIN-525 for the treatment of Crohn's disease; and other microbiome product candidates. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; and license agreements with Skysong Innovations LLC, OpenBiome, Arizona State University, and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Boston, Massachusetts.
Read More on Finch Therapeutics Group

Today's Range

Now: $13.62
Low: $13.35
High: $14.75

50 Day Range

MA: $13.09
Low: $11.52
High: $14.56

52 Week Range

Now: $13.62
Low: $10.15
High: $16.10

Volume

9,781 shs

Average Volume

3,029 shs

Market Capitalization

$21.93 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.17

Who are the company insiders with the largest holdings of Finch Therapeutics Group?

Finch Therapeutics Group's top insider investors include:
  1. Jeffery A Smisek (Director)
Learn More about top insider investors at Finch Therapeutics Group.